INVO Stock Analysis
IN
Uncovered
INVO Bioscience Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
IINVO BioScience, Inc. is a fertility company. The company is headquartered in Lakewood Ranch, Florida and currently employs 10 full-time employees. The company went IPO on 2008-11-11. The firm is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. Its flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its INVOcells inner chamber holds egg and sperm in a culture medium. Its INVO Centers offer the INVOcell and intravaginal culture (IVC) procedure, in addition to its selling of technology solutions into existing fertility clinics. The firm's subsidiaries include Bio X Cell, Inc., and Invo Centers, LLC.